Global DNA Sequencing Market Size to Register 11.3% CAGR Through 2027

The research report on ‘global DNA Sequencing market’ offers crucial insights such as the primarily growth stimulants, challenges & limitations and other expansion trends that are projected to formulate the growth rate of this business vertical over the period of 2020-2027. It also provides a comparative assessment of the historical data and prevailing market trends.

Global DNA Sequencing Market is valued at approximately USD 4.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11.3% over the forecast period 2020-2027. DNA sequencing is a process of identifying or determining the nucleic acid sequence within a DNA molecule. DNA sequencing enables scientists and researchers to sequence genomes and genes. After detecting and analyzing the genes from sequence information, researchers can obtain information concerning mutations that cause disease, thus offering considerable medical information. Also, the emergence of rapid DNA sequencing procedures has greatly accelerated medical and biological research and discover.

According to Centers for Genetics and Society, more than 26 million individuals have added their DNA tests to commercial ancestry and health databases by the start of year 2019, representing an increase of about 11 million from 2018. While as per the International Agency for Research on Cancer (IARC), globally, there were almost 18.1 million new cases of cancer and is likely to reach almost 27.5 million new cancer cases by the year 2040. Thus, the rise in number of DNA tests and cancer patients are likely to promote the adoption of the DNA sequencing all over the world. However, interpretation of complex data and the dearth of skilled professionals are the major factors limiting the market growth over the forecast period of 2020-2027.

Request Sample copy of this Report @  

Further, the use of DNA sequencing has become vital for basic biological research and applied in a wide range of medical fields such as biotechnology, medical diagnosis, virology, biological systematics, and forensic biology, which may contribute to the higher growth of the market worldwide. Furthermore, the rise in number of DNA tests, increasing number of cancer patients, and rapid advancements in sequencing technology and bioinformatics are the few factors responsible for the CAGR of the market during the forecast period.

Global DNA Sequencing Market Competitive Landscape Analysis (Revenue, USD billion, 2020-2027)

  • Agilent Technologies Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Qiagen
  • F. Hoffmann-La Roche Ltd.
  • Macrogen, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Perkin Elmer, Inc.
  • Pacific Biosciences of California, Inc.
  • Bio-Rad Laboratories, Inc.

The regional analysis of the global DNA Sequencing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the early adoption of technologically-advanced products and procedures, along with the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of cancer due to growing geriatric population coupled with rise in awareness and adoption of DNA sequencing solutions in developing countries, such as China and India, would create lucrative growth prospects for the DNA Sequencing market across the Asia-Pacific region.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market.

To access a sample copy or view this report in detail along with the table of contents, please click the link below: 

Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product & Services:

  • Consumables
  • Instruments
  • Services

By Technology:

  • Sanger Sequencing
  • Next-Generation Sequencing
  • Third Generation DNA Sequencing

By Workflow:

  • Pre-sequencing
  • Sequencing
  • Data Analysis

By Application:

  • Oncology
  • Reproductive Health
  • Clinical Investigation
  • Agrigenomics & Forensics
  • HLA Typing/Immune System Monitoring
  • Others

By End-Use:

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other Users

Global DNA Sequencing Market Regional Analysis (Revenue, USD billion, 2020-2027)

North America

  • U.S.
  • Canada


  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico

Rest of the World

Related Report:

Stents Market Size By Product, By Material, By Type, By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

Stents market is expected to exceed USD 14.0 billion in terms of value and 19.5 million units in terms of volume by 2025. Surge in number of peripheral and coronary artery surgical procedures along with growing demand for minimally invasive techniques will propel stents market growth.

Demand for stents will be majorly affected by growing prevalence of cardiovascular diseases due to adoption of sedentary and unhealthy lifestyle. Rising elderly population base that requires peripheral coronary intervention (PCI) procedure for treatment of blockage will further boost the industry growth. For instance, as per the CDC estimates, about 8.5 million people in the U.S. are diagnosed with peripheral artery disease (PAD) and the number is further estimated to grow over the coming years. Increasing number of people suffering from PAD will upsurge the demand for stents during the forecast timeframe.

About US:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

Contact Us:

Corporate Sales,

Market Study Report LLC

Phone: 1-302-273-0910

Toll Free: 1-866-764-2150


Back to news